class action lawsuit semaglutide Hims & Hers Health, Inc. (HIMS) Securities Update [July 28, 2025] Ozempic makers face proposed class
Pay in 4 interest-free payments of $7.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
![class action lawsuit semaglutide Hims & Hers Health, Inc. (HIMS) Securities Update [July 28, 2025] Ozempic makers face proposed class](https://i.ytimg.com/vi/RnnlbQz3Mtk/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLAyIEge0th2g9LkVoIcAx_tgegZBQ)
![class action lawsuit semaglutide Hims & Hers Health, Inc. (HIMS) Securities Update [July 28, 2025] Ozempic makers face proposed class](https://static.wixstatic.com/media/4c359e_7b8937ab160845949075a81daab4b18e~mv2.webp/v1/fill/w_568,h_378,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/4c359e_7b8937ab160845949075a81daab4b18e~mv2.webp)
![class action lawsuit semaglutide Hims & Hers Health, Inc. (HIMS) Securities Update [July 28, 2025] Ozempic makers face proposed class](https://pbs.twimg.com/media/HFPo2tmbUAApyvs.jpg)




















